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LETTERS TO THE EDITOR
The Chemokine Receptor CCR6 Identi¢es Interferon-c
Expressing T Cells and is Decreased in Atopic Dermatitis as
Compared with Psoriasis
To the Editor:
Atopic dermatitis (AD) is associated with an increased produc-
tion of T helper (Th) 2 cytokines such as interleukin (IL)-4 and
IL-13 and a decrease in the production of theTh1 cytokine, inter-
feron (IFN)-g, in the peripheral blood and acute skin lesions (Jujo
et al, 1992; Hamid et al, 1994). Increased Th2 cytokines leads to the
synthesis of IgE and induction of adhesion molecules that are in-
volved in the migration of allergic in£ammatory cells such as eo-
sinophils into the skin lesions (Akdis et al, 1999; Bochner, 2000).
On the other hand, a decrease in IFN-g contributes to the pro-
duction of Th2 cytokines and IgE synthesis as this cytokine
downregulates Th2 responses (Leung, 2000).
Chemokines are a group of polypeptides that recruit
leukocytes to the site of tissue in£ammation (Lukacs et al,
2001). CCR6 is a chemokine receptor that has been shown to be
highly expressed in skin-homing CLAþ (cutaneous lymphoid
antigen) memory T cells (Homey et al, 2000). The chemokine,
CCL20 (previously known as macrophage in£ammatory
protein-3a, MIP-3a) has been identi¢ed as the natural ligand
for CCR6 (Rossi et al, 1997; Greaves et al, 1997). Expression
of CCR6 has been shown to be upregulated in psoriasis
(Homey et al, 2000); however, the cytokine expression of
CCR6þ T cells in psoriasis were not determined. Therefore, we
were interested in determining whether CCR6þ T cells are de-
creased in AD and whether they are associated with increased
IFN-g expression.
Six patients with moderate to severe chronic AD of more
than 1 y (skin involvement of 15^80%) and two control
groups were studied: (i) six normal subjects with no history
of AD, allergic rhinitis, or asthma, and (ii) six patients with
psoriasis (skin involvement of 10^70%). Flow cytometry was
used to examine the frequency of blood CCR6þ Tcells. Expres-
sion of IFN-g and IL-4 was studied using intracellular cytokine
staining.
Table I summarizes the mean percentages of CD3þ/CCR6þ ,
CD4þ/CCR6þ , and CD8þ/CCR6þ T cells in the
study groups. The percentage of CD3þ/CCR6þ T cells was sig-
ni¢cantly lower in AD patients compared with that of psoriasis
patients (po0.05). Comparison of the expression of CCR6 in
the CD4þ and CD8þ T cell populations in the three study
groups showed similar results with AD patients having signi¢-
cantly lower percentages of CD4þ/CCR6þ and CD8þ/
CCR6þ blood T cells compared with that of psoriasis patients
(po0.05). This table also shows that within the T cell compart-
ment, CCR6 is mainly expressed by the CD4þ cells in all three
study groups.
As CCR6 is mainly expressed by CD4þ cells within theTcell
compartment, we also compared the expression of CCR6 in
CD4þ T cells, which express the skin-homing receptor, CLA,
in the three study groups. Our data show that both AD patients
and normal subjects have a signi¢cantly lower percentage of
CD4þ/CLAþ /CCR6þ T cells than that of psoriasis patients
(po0.05). There was no signi¢cant di¡erence between the per-
centage of CD4þ/CLAþ /CCR6þ T cells between AD patients
and normal subjects.
Table II shows the expression of IFN-g and IL-4 by CCR6þ
blood T cells in the study groups. IFN-g was expressed by
46.378.1% of CD4þ/CCR6þ T cells in AD patients,
53.072.8% in psoriasis patients, and 62.879.2% in normal
subjects, whereas only 9.478.1% of the CD4þ/CCR6 T cells
in AD, 14.172.8% in psoriasis and 9.679.2% in normal
subjects express IFN-g (po0.05). On the other hand, the
percentage of CD4þ/CCR6þ blood T cells expressing IL-4
was relatively low in all three study groups, with values of
0.870.6% in AD patients, 1.170.5% in psoriasis patients, and
0.370.2% in normal subjects. The expression of IL-4 in the
CD4þ/CCR6 T cell population was signi¢cantly higher than
CD4þ/CCR6þ T cells for all three study groups (po0.05).
Therefore, CD4þ/CCR6þ blood T cells are associated with
increased IFN-g, expression compared with CD4þ/CCR6
blood T cells.
This study demonstrates that the frequency of CCR6þ blood
T cells are decreased in AD compared with that of another in-
£ammatory skin disease, i.e., psoriasis. This is of interest as psor-
iasis has been shown to be primarily a Th1-mediated skin disease
associated with increased CCR6 cells in the CLAþ T cell subset
(Schlaak et al, 1994). This latter study did not examine cytokine
expression of CCR6 cells. Our results therefore extend this ¢nd-
ing in that we have found CCR6þ cells in the CD4þ Tcell sub-
set, of all three groups of study subjects, to be associated with
increased IFN-g expression compared with CD4þ/CCR6 T
cells.
This decrease in CD4þ/CLAþ /CCR6þ T cells may play an
important part in the increased Th2 cytokine pro¢le seen in acute
AD skin lesions as compared with psoriasis skin lesions (Hamid




AD (n¼ 6) 4.471.1%b 5.871.5%b 1.871.1%a
Normal (n¼ 6) 6.772.9% 7.572.2% 3.171.2%
Psoriasis (n¼ 6) 9.373.3% 12.274.8% 4.171.3%
aIn these experiments, peripheral blood mononuclear cells from the study
subjects were stained with phycoerythrin-conjugated anti-CCR6 or an iso-
type-matched antibody (R&D Systems, Inc., Minneapolis, MN), and Peridinin
Chlorophyll protein-conjugated anti-CD3, and antigen-presenting cell-conjugated
anti-CD4 or anti-CD8 for 30 min. Analysis was performed using a FACScalibur
£ow cytometer (Becton Dickinson, San Jose, CA). An isotype-matched antibody
control was used to verify the staining speci¢city of CCR6. bpo0.05, as compared
with psoriasis.
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et al, 1996). In mouse models of AD, it has been found that IFN-g
de¢ciency is associated with increased systemic and skin directed
Th2 responses (Habu et al, 2001). Interestingly, it has been shown
that chronic AD skin lesions have a higher level of CCL20 and
CCR6 compared with normal skin (Nakayama et al, 2001). Based
on our observation that CCR6 is a marker for IFN-g expressing
T cells, an increased in¢ltration of CD4þ/CLAþ /CCR6þ T
cells to chronic AD skin lesions may account for the increased
IFN-g expression in these lesions as compared with normal skin
(Grewe et al, 1994).
The increased Th2 cytokine pro¢le in AD skin lesions
likely occurs as the result of T cells expressing other chemokine
receptors that contribute to polarization of the Th2 immune
response. A recent study has shown that the frequency of
blood CD4þ/CCR4þ T cells, which are associated with in-
creased IL-4 expression, is increased in AD patients (Nakatani et
al, 2001). Therefore, the combination of both a decrease in
CD4þ/CCR6þ T cells and an increase in CD4þ/CCR4þ T
cells may further increase the predominance of Th2 cytokines in
AD.
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Table II. IFN-g and IL-4 expression in CD4/CCR6þ and
CD4/CCR6 Tcellsa
%IFN-g in: %IL-4 in:
CD4/CCR6þ CD4/CCR6 CD4/CCR6þ CD4/CCR6
AD (n¼ 6) 46.378.1%b 9.478.1% 0.870.6%b 3.170.6%
Normal (n¼ 6) 62.879.2%b 9.679.2% 0.370.2%b 1.770.2%
Psoriasis (n¼ 6) 53.072.8%b 14.172.8% 1.170.5%b 3.570.5%
a2106 peripheral blood mononuclear cells per ml were stimulated with 50 ng
per ml phorbol myristate acetate and 1 mg per ml ionomycin in the presence of 10
mg per ml brefeldin A (Sigma, St. Louis, MO) in RPMI 1640 with 10% fetal
bovine serum for 4 h at 371C. The cells were then spun down and resuspended
in staining solution at 2107 per ml and incubated in a 96-well microtiter plate
with phycoerythrin-conjugated anti-CCR6 or an isotype-matched antibody and
Peridinin Chlorophyll protein-conjugated anti-CD4 for 30 min at 41C. The cells
were spun down and incubated for 10 min with £uorescence-activated cell sorter-
lysing solution and permealizing solution (B-D Pharmigen, San Diego, CA) at
room temperature. The cells were then washed once with wash bu¡er and resus-
pended at 2107 per ml in staining solution and incubated with £uorescein iso-
thiocyanate-conjugated anti-IFN-g and antigen-presenting cell-conjugated anti-
IL-4 (Becton-Dickinson) for 30 min at room temperature. The cells were then
washed two times and ¢xed in 1% paraformaldehyde solution for four-color £ow
cytometric analyses. bpo0.05 as compared with CD4/CCR6 cells.
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